A constitutive nitric oxide synthase modulates insulin secretion in the INS-1 cell line.
P Beffy, A D Lajoix, P Masiello, S Dietz, S Péraldi-Roux, T Chardès, G Ribes, R Gross
Index: Mol. Cell. Endocrinol. 183(1-2) , 41-8, (2001)
Full Text: HTML
Abstract
We provide immunocytochemical evidence that the neuronal isoform of constitutive NO synthase (cNOS) is expressed in the rat insulinoma cell line INS-1. Furthermore, using N omega-nitro-L-arginine methyl ester (L-NAME), a pharmacological inhibitor of cNOS activity, we show that this enzyme is implicated in the modulation of insulin secretion in INS-1 cells. Indeed, in the presence of 2.8 mM glucose, L-NAME induced a specific and dose-dependent increase in insulin release, suggesting that cNOS exerts an inhibitory tone on basal insulin secretion. Moreover, L-arginine, the physiological substrate of cNOS, significantly reduced the marked enhancing effect of L-NAME on insulin release and to a lesser extent, at low concentrations, that of 10 mM KCl. L-NAME also potentiated the insulin secretion stimulated by 5.5 and 8.3 mM glucose, but in this case, its effect was not reduced by L-arginine. In conclusion, our data show that the neuronal isoform of cNOS exerts a negative modulation on insulin secretion in INS-1 cells, confirming the previous results obtained in the isolated perfused rat pancreas or pancreatic islets.
Related Compounds
Related Articles:
1994-06-01
[Clin. Chem. 40(6) , 862-6, (1994)]
2012-11-01
[Anal. Bioanal. Chem 404(8) , 2349-61, (2012)]
2000-04-01
[Am. J. Clin. Nutr. 71(4) , 978-86, (2000)]
2011-10-01
[Water Res. 45(15) , 4459-69, (2011)]
1983-03-01
[Clin. Chem. 29(3) , 434-7, (1983)]